Published in J Mol Biol on December 20, 2005
A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells. Cell Death Dis (2012) 0.94
CLT1 targets angiogenic endothelium through CLIC1 and fibronectin. Angiogenesis (2011) 0.82
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science (1996) 16.69
RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol (1996) 9.77
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (1998) 8.11
Peptide antibiotics and their role in innate immunity. Annu Rev Immunol (1995) 6.81
Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem (2002) 6.01
Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell (2005) 5.75
Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature (2002) 5.32
Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature (2005) 4.20
Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med (1999) 3.72
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24
An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry (1996) 3.16
How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? Anal Biochem (2000) 2.79
A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom. Nature (2004) 2.74
Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science (1997) 2.38
Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell (1994) 2.23
Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res (2002) 2.21
Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell (2003) 2.15
Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci (2005) 2.08
The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol (2001) 1.85
Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration. J Clin Invest (2002) 1.67
From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides (2001) 1.66
Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood (1996) 1.64
The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions. Nat Struct Biol (1994) 1.63
Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. Br J Cancer (2001) 1.62
A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc Natl Acad Sci U S A (2001) 1.61
A simple approach to membrane protein secondary structure and topology based on NMR spectroscopy. Biophys J (2001) 1.55
Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett (2001) 1.52
Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett (1997) 1.47
Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry (1994) 1.43
Rotavirus capsid protein VP5* permeabilizes membranes. J Virol (1999) 1.42
Cell permeant polyphosphoinositide-binding peptides that block cell motility and actin assembly. J Biol Chem (2001) 1.35
Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells. Mol Membr Biol (1995) 1.35
Staphylococcus aureus alpha-toxin-induced cell death: predominant necrosis despite apoptotic caspase activation. Cell Death Differ (2003) 1.35
Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol Microbiol (2001) 1.32
Three-dimensional solid-state NMR spectroscopy is essential for resolution of resonances from in-plane residues in uniformly (15)N-labeled helical membrane proteins in oriented lipid bilayers. J Magn Reson (2000) 1.31
Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO J (1998) 1.31
A novel linear amphipathic beta-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids. J Biol Chem (2001) 1.30
A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice. Cancer Res (2005) 1.29
Anginex, a designed peptide that inhibits angiogenesis. Biochem J (2001) 1.27
Orientation of cecropin A helices in phospholipid bilayers determined by solid-state NMR spectroscopy. Biophys J (1999) 1.27
Anastellin, an FN3 fragment with fibronectin polymerization activity, resembles amyloid fibril precursors. J Mol Biol (2003) 1.21
Inhibition of angiogenesis by Abeta peptides. Angiogenesis (2004) 1.19
Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino Acid Peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res (2004) 1.15
Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells. Int J Cancer (2005) 1.13
Dispensable nature of phosphatidylglycerol in Escherichia coli: dual roles of anionic phospholipids. Mol Microbiol (2001) 1.11
Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature. Proc Natl Acad Sci U S A (2005) 1.10
The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models. FASEB J (2002) 1.09
Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity. Proc Natl Acad Sci U S A (2003) 1.04
NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer. Biochemistry (1995) 1.04
Platelet factor 4: an inhibitor of angiogenesis. Semin Thromb Hemost (2004) 1.02
Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. J Biol Chem (1993) 1.01
Measurement of apoptosis by DNA fragmentation. Methods Mol Biol (2004) 1.01
The structure of mouse tumour-necrosis factor at 1.4 A resolution: towards modulation of its selectivity and trimerization. Acta Crystallogr D Biol Crystallogr (1999) 0.95
The heparin-binding site of antithrombin is crucial for antiangiogenic activity. Blood (2005) 0.94
Recombinant endostatin forms amyloid fibrils that bind and are cytotoxic to murine neuroblastoma cells in vitro. FEBS Lett (2003) 0.94
A folding pathway for betapep-4 peptide 33mer: from unfolded monomers and beta-sheet sandwich dimers to well-structured tetramers. Protein Sci (1998) 0.92
Beta-sheet is the bioactive conformation of the anti-angiogenic anginex peptide. Biochem J (2003) 0.89
Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers. Biochemistry (2005) 0.87
Endostatin's endpoints-Deciphering the endostatin antiangiogenic pathway. Cancer Cell (2004) 0.86
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science (2010) 6.01
Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A (2002) 5.35
Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater (2009) 4.77
Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell (2009) 4.02
Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater (2011) 3.83
Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci U S A (2007) 3.26
Structure determination of membrane proteins by NMR spectroscopy. Chem Rev (2004) 3.25
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell (2004) 3.09
Structure of the chemokine receptor CXCR1 in phospholipid bilayers. Nature (2012) 2.88
A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med (2002) 2.77
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol (2003) 2.68
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell (2003) 2.56
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci U S A (2009) 2.41
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc Natl Acad Sci U S A (2002) 2.35
Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem (2007) 2.31
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. Cancer Res (2008) 2.13
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell (2003) 2.07
Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol (2010) 2.05
Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A (2002) 2.01
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging. Adv Mater (2008) 2.01
In vivo tumor cell targeting with "click" nanoparticles. Bioconjug Chem (2008) 2.01
Targeting of albumin-embedded paclitaxel nanoparticles to tumors. Nanomedicine (2008) 1.90
Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci U S A (2009) 1.82
Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci U S A (2004) 1.82
Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci U S A (2009) 1.76
A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell (2004) 1.73
Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl (2008) 1.71
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci U S A (2006) 1.68
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc Natl Acad Sci U S A (2011) 1.68
Dipolar waves as NMR maps of protein structure. J Am Chem Soc (2002) 1.66
Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels. Cancer Cell (2012) 1.56
Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1. Protein Sci (2002) 1.54
R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis. Nat Med (2005) 1.51
Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis. Proc Natl Acad Sci U S A (2011) 1.45
Crystal structure of a human peptidyl-tRNA hydrolase reveals a new fold and suggests basis for a bifunctional activity. J Biol Chem (2003) 1.44
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci Transl Med (2012) 1.42
Dipolar waves map the structure and topology of helices in membrane proteins. J Am Chem Soc (2003) 1.40
Proteolytic actuation of nanoparticle self-assembly. Angew Chem Int Ed Engl (2006) 1.39
Structure determination of a membrane protein in proteoliposomes. J Am Chem Soc (2012) 1.37
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci U S A (2013) 1.37
Nanoparticle-induced vascular blockade in human prostate cancer. Blood (2010) 1.30
Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci U S A (2002) 1.26
Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv Mater (2010) 1.26
A high-throughput label-free nanoparticle analyser. Nat Nanotechnol (2011) 1.24
Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res (2010) 1.23
Structure of the Na,K-ATPase regulatory protein FXYD1 in micelles. Biochemistry (2007) 1.23
Cell spreading controls endoplasmic and nuclear calcium: a physical gene regulation pathway from the cell surface to the nucleus. Proc Natl Acad Sci U S A (2003) 1.22
Anastellin, an FN3 fragment with fibronectin polymerization activity, resembles amyloid fibril precursors. J Mol Biol (2003) 1.21
Mapping of vascular ZIP codes by phage display. Methods Enzymol (2012) 1.21
Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials (2009) 1.19
Lymphatic zip codes in premalignant lesions and tumors. Cancer Res (2006) 1.18
Structure and dynamics of the membrane-bound form of Pf1 coat protein: implications of structural rearrangement for virus assembly. Biophys J (2010) 1.15
Synthetic surfaces for human embryonic stem cell culture. J Biotechnol (2010) 1.13
De novo design of a tumor-penetrating peptide. Cancer Res (2012) 1.12
Molecular profiling of heart endothelial cells. Circulation (2005) 1.11
Protein kinase D is a positive regulator of Bit1 apoptotic function. J Biol Chem (2008) 1.11
Anoikis effector Bit1 negatively regulates Erk activity. Proc Natl Acad Sci U S A (2008) 1.11
Structural similarity of a membrane protein in micelles and membranes. J Am Chem Soc (2007) 1.10
Lymphangiogenesis and cancer: meeting report. Cancer Res (2004) 1.10
Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Mol Cancer Res (2007) 1.10
Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature. Proc Natl Acad Sci U S A (2005) 1.10
Molecular changes in the vasculature of injured tissues. Am J Pathol (2007) 1.08
Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Angiogenesis (2009) 1.08
FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its beta1 subunit. J Biol Chem (2011) 1.07
A surface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles. Small (2009) 1.07
Tumor-penetrating peptides. Front Oncol (2013) 1.06
Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles. Langmuir (2009) 1.06
Orientation of the Escherichia coli outer membrane protein OmpX in phospholipid bilayer membranes determined by solid-State NMR. Biochemistry (2008) 1.06
NMR of membrane proteins in micelles and bilayers: the FXYD family proteins. Methods (2007) 1.05
Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity. Proc Natl Acad Sci U S A (2003) 1.04
alpha5beta1 integrin stimulates Bcl-2 expression and cell survival through Akt, focal adhesion kinase, and Ca2+/calmodulin-dependent protein kinase IV. J Cell Biochem (2005) 1.04
Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model. Biomaterials (2008) 1.03
Structural studies of apoptosis and ion transport regulatory proteins in membranes. Magn Reson Chem (2004) 1.03
Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads. Small (2010) 1.02
Solid-state NMR spectroscopy of a membrane protein in biphenyl phospholipid bicelles with the bilayer normal parallel to the magnetic field. J Magn Reson (2008) 1.02
NMR-based simulation studies of Pf1 coat protein in explicit membranes. Biophys J (2013) 1.01
Conformation of membrane-associated proapoptotic tBid. J Biol Chem (2004) 1.01
Serine 68 phospholemman phosphorylation during forskolin-induced swine carotid artery relaxation. J Vasc Res (2005) 1.00
Correlation of gene and protein structures in the FXYD family proteins. J Mol Biol (2005) 1.00
The uronium/guanidinium Peptide coupling reagents: finally the true uronium salts. Angew Chem Int Ed Engl (2002) 1.00
TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells. Mol Cancer Res (2012) 0.98
Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice. Proc Natl Acad Sci U S A (2010) 0.97
Selection of phage-displayed peptides on live adherent cells in microfluidic channels. Proc Natl Acad Sci U S A (2011) 0.97
X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew Chem Int Ed Engl (2011) 0.96
Synthesis of novel beta-lactone inhibitors of fatty acid synthase. J Med Chem (2008) 0.95
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32. Mol Ther (2013) 0.95
NMR structural studies of the bacterial outer membrane protein OmpX in oriented lipid bilayer membranes. Biochim Biophys Acta (2007) 0.95
Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (2011) 0.95
Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides. J Virol (2006) 0.95
Mapping the interaction of pro-apoptotic tBID with pro-survival BCL-XL. Biochemistry (2009) 0.94
The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies. J Biol Chem (2010) 0.94
Metastasis of tumor cells is enhanced by downregulation of Bit1. PLoS One (2011) 0.94
Bcl-XL as a fusion protein for the high-level expression of membrane-associated proteins. Protein Sci (2005) 0.94
Peptide-directed highly selective targeting of pulmonary arterial hypertension. Am J Pathol (2011) 0.93